Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

AtriCure cryoICE cryo-ablation probe (CRYO2)

K-Number: K180138 · 2018-02-15

Decision Date2018-02-15
Product CodeGXH
Advisory CommitteeNE
DecisionSubstantially Equivalent

Device Summary

AtriCure cryoICE cryo-ablation probe (CRYO2) is a medical device manufactured by AtriCure, Inc.. It received FDA 510(k) clearance on 2018-02-15 under approval number K180138. The device is classified under product code GXH. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the AtriCure cryoICE cryo-ablation probe (CRYO2)?

AtriCure cryoICE cryo-ablation probe (CRYO2) is a medical device that received FDA 510(k) clearance on 2018-02-15. It is manufactured by AtriCure, Inc.. The 510(k) number is K180138.

When was AtriCure cryoICE cryo-ablation probe (CRYO2) approved by the FDA?

AtriCure cryoICE cryo-ablation probe (CRYO2) received FDA 510(k) clearance on 2018-02-15, under approval number K180138.

What company makes AtriCure cryoICE cryo-ablation probe (CRYO2)?

AtriCure cryoICE cryo-ablation probe (CRYO2) is manufactured by AtriCure, Inc..

What is the FDA product code for AtriCure cryoICE cryo-ablation probe (CRYO2)?

The FDA product code for AtriCure cryoICE cryo-ablation probe (CRYO2) is GXH.

Related Clinical Trials

Other Devices by AtriCure, Inc.

View all 34 devices →

Related Devices (Code: GXH)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.